Funded Tech Companies
TScan Therapeutics
Looking for the VC firms that provided funding to TScan Therapeutics? GV, Novartis Venture Fund and BlackRock joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
TScan Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
830 Winter St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Company Background Information
Overview
TScan Therapeutics is an experienced group of scientists, development specialists, and other leaders driving a cutting edge platform. TScan Therapeutics is an owner and operator of a biotechnology company intended to develop immunotherapy treatments for cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/16/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Southwell
Chief Scientific Officer
Gavin MacBeath
VP - Bus. Development
Henry Rath
VP - Finance
Shane Maltbie
VP - Human Resources
Ann Hargraves
Company Investors
- GV
- Novartis Venture Fund
- BlackRock
- 6 Dimensions Capital
- Longwood Fund
- Bessemer Venture Partners
- Pitango Venture Capital
- RA Capital
- Novartis Institutes for BioMedical Research
- Astellas Venture Capital
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs